ANRO vs. CVKD
ANRO (Alto Neuroscience, Inc) and CVKD (Cadrenal Therapeutics Inc. Common Stock) are both stocks. Both operate in the Biotechnology industry within the Healthcare sector. Over the past year, ANRO returned 919.11% vs -74.25% for CVKD. At a 0.15 correlation, their price movements are largely independent.
Performance
ANRO vs. CVKD - Performance Comparison
Loading charts...
Returns By Period
In the year-to-date period, ANRO achieves a 28.82% return, which is significantly higher than CVKD's -53.10% return.
ANRO
- 1D
- 0.84%
- 1M
- 8.06%
- YTD
- 28.82%
- 6M
- 14.42%
- 1Y
- 919.11%
- 3Y*
- —
- 5Y*
- —
- 10Y*
- —
CVKD
- 1D
- -9.14%
- 1M
- -38.73%
- YTD
- -53.10%
- 6M
- -57.80%
- 1Y
- -74.25%
- 3Y*
- -49.02%
- 5Y*
- —
- 10Y*
- —
ANRO vs. CVKD - Yearly Performance Comparison
| 2026 (YTD) | 2025 | 2024 | |
|---|---|---|---|
ANRO Alto Neuroscience, Inc | 28.82% | 320.80% | -80.77% |
CVKD Cadrenal Therapeutics Inc. Common Stock | -53.10% | -53.21% | -31.49% |
Correlation
The correlation between ANRO and CVKD is 0.18, which is low. Their price movements are largely independent, making them effective diversification partners.
| Correlation | |
|---|---|
Correlation (1Y) Calculated over the trailing 1-year period | 0.18 |
Correlation (All Time) Calculated using the full available price history since Feb 2, 2024 | 0.15 |
Fundamentals
ANRO:
$754.24M
CVKD:
$6.34M
ANRO:
-$2.50
CVKD:
-$5.10
ANRO:
3.10
CVKD:
2.31
ANRO:
$0.00
CVKD:
$0.00
ANRO:
-$421.00K
CVKD:
-$5.92K
ANRO:
-$74.36M
CVKD:
-$13.32M
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Return for Risk
ANRO vs. CVKD — Risk / Return Rank
ANRO
CVKD
ANRO vs. CVKD - Risk-Adjusted Trends Comparison
This table presents a comparison of risk-adjusted performance metrics for Alto Neuroscience, Inc (ANRO) and Cadrenal Therapeutics Inc. Common Stock (CVKD). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
Values are calculated on a 1-year rolling basis and updated daily. Risk-adjusted metrics are more stable over longer periods — use the period switch above to explore them.
| ANRO | CVKD | Difference | |
|---|---|---|---|
| Sharpe ratioReturn per unit of total volatility | +7.97 | ||
| Sortino ratioReturn per unit of downside risk | +6.90 | ||
| Omega ratioGain probability vs. loss probability | 1.72 | 0.86 | +0.86 |
| Calmar ratioReturn relative to maximum drawdown | 27.15 | -0.95 | +28.10 |
| Martin ratioReturn relative to average drawdown | 70.91 | -1.75 | +72.66 |
Loading charts...
Drawdowns
ANRO vs. CVKD - Drawdown Comparison
The maximum ANRO drawdown since its inception was -91.82%, roughly equal to the maximum CVKD drawdown of -96.45%. Use the drawdown chart below to compare losses from any high point for ANRO and CVKD.
Loading charts...
Drawdown Indicators
| ANRO | CVKD | Difference | |
|---|---|---|---|
Max DrawdownLargest peak-to-trough decline | -91.82% | -96.45% | +4.63% |
Max Drawdown (1Y)Largest decline over 1 year | -34.20% | -78.59% | +44.39% |
Max Drawdown (3Y)Largest decline over 3 years | — | -90.99% | — |
Current DrawdownCurrent decline from peak | -17.28% | -96.29% | +79.01% |
Average DrawdownAverage peak-to-trough decline | -53.30% | -84.77% | +31.47% |
Ulcer IndexDepth and duration of drawdowns from previous peaks | 13.07% | 42.39% | -29.32% |
Volatility
ANRO vs. CVKD - Volatility Comparison
The current volatility for Alto Neuroscience, Inc (ANRO) is 24.19%, while Cadrenal Therapeutics Inc. Common Stock (CVKD) has a volatility of 26.09%. This indicates that ANRO experiences smaller price fluctuations and is considered to be less risky than CVKD based on this measure. The chart below showcases a comparison of their rolling one-month volatility.
Loading charts...
Volatility by Period
| ANRO | CVKD | Difference | |
|---|---|---|---|
Volatility (1M)Calculated over the trailing 1-month period | 24.19% | 26.09% | -1.90% |
Volatility (6M)Calculated over the trailing 6-month period | 54.92% | 68.56% | -13.64% |
Volatility (1Y)Calculated over the trailing 1-year period | 128.77% | 100.24% | +28.53% |
Volatility (5Y)Calculated over the trailing 5-year period, annualized | 115.37% | 102.28% | +13.09% |
Volatility (10Y)Calculated over the trailing 10-year period, annualized | 115.37% | 102.28% | +13.09% |
Dividends
ANRO vs. CVKD - Dividend Comparison
Neither ANRO nor CVKD has paid dividends to shareholders.
Financials
ANRO vs. CVKD - Financials Comparison
This section allows you to compare key financial metrics between Alto Neuroscience, Inc and Cadrenal Therapeutics Inc. Common Stock. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.
Total Revenue: Total amount of money received from sales and other business activities
Frequently Asked Questions
ANRO and CVKD have a correlation of 0.18, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.
CVKD has higher volatility (26.09%) compared to ANRO (24.19%). In terms of maximum drawdown, ANRO dropped -91.82% vs CVKD's -96.45%.
ANRO currently has the higher Sharpe Ratio (7.23 vs -0.74), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.
Find the right allocation for ANRO and CVKD
Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.
Open Portfolio Optimizer